A Global Deep Learning Model for Global Health Drug Discovery
This webinar was presented by Samar Mahmoud and Matt Segall.
In this webinar, we described the generation and validation of a ‘global’ deep learning model for drug discovery using imputation on a data set of 300,000 compounds and 500 experimental endpoints, targeting global health indications.
We demonstrated how this global model can be applied to individual optimisation projects, offering improved compounds design performance over ‘local’ project-specific models by learning across a broad chemical diversity.
Even including unrelated endpoints from many projects does not cause a loss of performance for individual projects and endpoints – an example of “build once, run everywhere.”
If you can’t play the video above, please use this link.
INTERESTED IN AI FOR DRUG DISCOVERY?
Cerella™ is a unique artificial intelligence platform which supports medicinal chemists and other discovery scientists. It escalates success rates and advances small molecule drug discovery, from working with early hits to nominating preclinical candidates.
Cerella’s AI platform is proven to overcome limitations in drug discovery data, confidently delivering results and seamlessly integrating with your med chem software platforms.